| |
| |
|
| Insider
Information: |
Weisner Aimee S |
| Relationship: |
|
| City: |
Santa Ana |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
104,515 |
|
|
Indirect Shares
|
17,000 |
|
|
| Direct
Value |
$3,734,974 |
|
|
|
Indirect Value
|
$1,785,170 |
|
|
| Total
Shares |
121,515 |
|
|
| Total
Value |
$5,520,144 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
1
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
6.0
|
-1.0
|
| Percentage
Gain/Loss : |
 49.9%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
CVP, General Counsel |
2011-05-12 |
1,675 |
2011-05-12 |
0 |
Premium* |
|
|
Glaukos Corp |
GKOS |
|
2024-01-02 |
28,403 |
2024-01-02 |
17,000 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
Director |
2023-01-03 |
0 |
2019-10-31 |
0 |
Premium* |
|
|
Lensar, Inc. |
LNSR |
Director |
2023-05-25 |
63,573 |
2022-05-25 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
|
2024-03-14 |
10,864 |
2023-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STAA |
STAAR Surgical Co |
|
– • – |
2024-03-14 |
4 |
B |
$38.11 |
$66,693 |
D/D |
1,750 |
10,864 |
0.01 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
28,403 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-12-29 |
4 |
A |
$31.21 |
$99,872 |
D/D |
3,200 |
9,114 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-09-29 |
4 |
A |
$40.18 |
$19,969 |
D/D |
497 |
5,914 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-08-07 |
4 |
B |
$48.72 |
$97,440 |
D/D |
2,000 |
5,417 |
2.39 |
% |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,417 |
3,417 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,230 |
27,508 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,288 |
63,573 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-22 |
4 |
B |
$2.75 |
$45,779 |
D/D |
16,647 |
54,285 |
2.39 |
% |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-19 |
4 |
B |
$2.59 |
$57,376 |
D/D |
22,153 |
37,638 |
2.39 |
% |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-18 |
4 |
B |
$2.61 |
$20,097 |
D/D |
7,700 |
15,485 |
2.39 |
% |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-17 |
4 |
B |
$2.29 |
$8,015 |
D/D |
3,500 |
7,785 |
2.39 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-03-08 |
4 |
OE |
$7.28 |
$72,750 |
D/D |
10,000 |
34,278 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,764) |
0 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
24,278 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
36,764 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,364 |
22,706 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,285 |
4,285 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,455 |
18,342 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2021-08-09 |
4 |
A |
$51.66 |
$103,320 |
I/I |
2,000 |
7,000 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
33,191 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,382 |
16,887 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
980 |
14,505 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
29,725 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
• • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,900 |
13,525 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
